Harnessing gene & cell therapy to end the HIV epidemic.

Our story begins with the recognition of a global crisis: the HIV epidemic.

Since the early 1980s, the epidemic has inflicted unimaginable pain, claiming the lives of over 40 million people worldwide.

To address this formidable challenge, we are pioneering a new generation of gene and cell based therapies, with the goal of delivering what was once thought impossible: a functional cure for HIV.

“All the patients I’ve lost are not here. But I am. And as long as I can be here to help fight this disease in their name, that’s fulfillment."

MARCUS CONANT, MD, CHIEF MEDICAL OFFICER

Our core beliefs.

Respect

We are deeply committed to the well-being and dignity of those affected by HIV/AIDS. With a profound understanding of the human aspect of our work, we embrace empathy and compassion towards those living with HIV.

Diversity

We firmly believe that diversity is the heart of innovation. We wholeheartedly embrace collaborative efforts that propel our knowledge, scientific advancements, and global impact.

Humanity

We are deeply committed to the well-being and dignity of those affected by HIV/AIDS. With a profound understanding of the human aspect of our work, we embrace empathy and compassion towards those living with HIV.

Determination

HIV never rests, and neither do we. We are unwavering in our pursuit of fulfilling the promise to end the HIV epidemic and conquer the virus once and for all.

The leadership of American Gene Technologies steers its HIV-focused division, Addimmune.

Jeff Galvin

CEO of American Gene Technologies™ and its HIV-focused division, Addimmune ™
Dr. Jeff Boyle

Jeff Boyle, PhD

Chief Science Officer

Marcus Conant, MD

Chief Medical Officer

Lola Liao, CPA

Director of HR & Admin
Andrew Miller

Barry Wells, MD

Head of Business Development

General Advisors

Scientific Advisors

Robert Redfield M.D.

Robert Redfield, MD

Scientific Advisor
Charles Flexner, M.D.

Charles Flexner, MD

Scientific Advisor
Michael Saag, M.D.

Michael Saag, MD

Scientific Advisor
Fred Nyberg

Fred Nyberg, PhD

Scientific Advisor

HIV Science Advisors

W. David Hardy, M.D.

W. David Hardy, MD

Scientific Advisor

John J. Rossi, PhD

Scientific Advisor

Ely Benaim, MD

HIV Science Advisor

Oncology Science Advisors

Robert Clarke, PhD, DSc

Scientific Advisor

Dean W. Felsher, MD, PhD

Scientific Advisor

PKU Science Advisors

Jerry Vockley, MD, PhD

Scientific Advisor